Table 2.
Primary and secondary endpoints after 6 months for intervention and control group
| t0 (baseline) | t1 (after 6 months) | Change within groups | Difference of change between groups | p | η² | |
|---|---|---|---|---|---|---|
| Primary endpoints | ||||||
| FMS score1 | ||||||
| CG (N = 29) | 11.1 (2.8) | 10.5 (3.1) | −0.6 (2.4) | 5.2 [4.1–6.3] | <0.001 | 0.58 |
| IG (N = 37) | 10.4 (2.6) | 15.0 (2.2) | 4.6 (2.1) | |||
| Secondary endpoints | ||||||
| TE (kg) | ||||||
| CG (N = 29) | 46.2 (17) | 48.4 (18.2) | 2.2 (9) | 18.9 [14.1–23.9] | <0.001 | 0.46 |
| IG (N = 37) | 52.0 (16.6) | 73.1 (20.7) | 21.1 (11.3) | |||
| TF (kg) | ||||||
| CG (N = 29) | 35.4 (15.9) | 34.7 (14) | −0.7 (6.3) | 12.8 [9.7–16.1] | <0.001 | 0.47 |
| IG (N = 37) | 38.5 (15) | 50.7 (17.9) | 12.2 (7.2) | |||
| TLFl (kg) | ||||||
| CG (N = 29) | 28.6 (12.4) | 30.0 (12.1) | 1.4 (4.7) | 13.4 [9.8–16.8] | <0.001 | 0.41 |
| IG (N = 37) | 34.4 (12.4) | 49.2 (13.4) | 14.8 (9.9) | |||
| TLFr (kg) | ||||||
| CG (N = 29) | 29.8 (12.8) | 30.6 (11.6) | 0.8 (5.5) | 13.2 [9.7–16.8] | <0.001 | 0.42 |
| IG (N = 37) | 36.4 (13) | 50.4 (13.6) | 14 (9.3) | |||
| UPush (kg) | ||||||
| CG (N = 28) | 62.4 (28.4) | 61.8 (29.2) | −0.6 (7.8) | 17.2 [12.4–22.4] | <0.001 | 0.4 |
| IG (N = 35) | 73.2 (31.7) | 89.8 (38.6) | 16.5 (12.5) | |||
| UPull (kg) | ||||||
| CG (N = 28) | 53.3 (22) | 54.4 (21.2) | 1.2 (6.4) | 8.7 [5.1–12.5] | <0.001 | 0.25 |
| IG (N = 35) | 60.1 (23.2) | 70.0 (25.8) | 9.9 (8.5) | |||
| HEl (kg) | ||||||
| CG (N = 29) | 38.1 (10.5) | 43.5 (13) | 5.4 (5.4) | 6.7 [3.4–10] | <0.001 | 0.18 |
| IG (N = 36) | 41.8 (12.8) | 53.8 (15.3) | 12 (8.4) | |||
| HEr (kg) | ||||||
| CG (N = 29) | 43.3 (13.8) | 41.3 (13.1) | −2.1 (6) | 13.4 [9.6–17.6] | <0.001 | 0.4 |
| IG (N = 36) | 47.2 (13.1) | 58.5 (15.6) | 11.3 (9.8) | |||
| WHO‐5 score2 | ||||||
| CG (N = 31) | 14.7 (3.3) | 16.0 (4.2) | 1.3 (3.6) | 0.5 [−1.1 to 2.3] | 0.55 | 0.01 |
| IG (N = 39) | 13.6 (4.7) | 15.4 (4.3) | 1.8 (3.7) | |||
Note: Mobility (FMS score), strength (kilograms), and well‐being (WHO‐5 score) values for t0, t1, and change within groups are expressed as mean (SD). Differences in change between groups are presented as mean [95% CI]. Partial η² is given for effect size.
Abbreviations: CG, control group; FMS, Functional Movement Screen; HEl, hip extension left; HEr, hip extension right; IG, intervention group; TE, trunk extension; TF, trunk flexion; TLFl, trunk lateral flexion left; TLFr, trunk lateral flexion right; UPush, upper body push; UPull, upper body pull.
1
A score from 0 to 21 can be achieved.
2
A score from 0 to 25 can be achieved.